Business Wire

Experts From Amazon Web Services and IDC Join Pyramid Executives on the Main Stage at SAPinsider 2022

14.7.2022 15:00:00 EEST | Business Wire | Press release

Share

The Chief Technology Officer and Senior Vice President of Strategic Alliances from Pyramid Analytics (Pyramid), a pioneering decision intelligence platform provider, will deliver main stage presentations with Chandana Gopal, Research Director, Future of Intelligence, IDC and Cristina Martin Greysman, WW Head of SAP on AWS Partner & Alliance Strategy at Amazon Web Services, at SAPinsider 2022, July 19 – 21 in Las Vegas.

Key Points:

  • Avi Perez, Chief Technology Officer, Pyramid Analytics and Chandana Gopal, Research Director, Future of Intelligence, IDC will discuss what’s possible in their session, “Decision Intelligence: What’s Next in Data and Analytics for SAP BW and HANA.”
  • Dave Henry, Senior Vice President of Strategic Alliances, Pyramid and Cristina Martin Greysman, WW Head of SAP on AWS Partner & Alliance Strategy at Amazon Web Services, will present “The ‘Beyond ERP’ Challenge: Maximizing the Use of SAP with Your Company’s Data Lake.”
  • Join us at Booth 1245 on the SAPinsider 2022 exhibition floor for demos and presentations about creating additional value in SAP environments with decision intelligence.
  • Come to SAPinsider 2022 in Las Vegas. Register with our discount code: PYRAMIDVIP.

The Pyramid Decision Intelligence Platform is the strongest analytics solution to run on SAP. The Pyramid Platform provides direct access. This eliminates the need to extract data out of SAP, protecting deep investment in SAP-driven business logic and security infrastructure. SAP data can also be blended with different data sources no matter where they reside to create a single view of a business and deliver reliable, consistent analytics.

Learn to Extract Maximum Value from SAP BW and HANA with Decision Intelligence

  • Day 1: Tuesday, July 19. 11:30 a.m. – 12:20 p.m.

Decision Intelligence: What’s Next in Data and Analytics for SAP BW and HANA
Presenters: Avi Perez, Chief Technology Officer, Pyramid Analytics and Chandana Gopal, Research Director, Future of Intelligence, IDC.
Abstract: Many organizations that have invested in SAP BW and HANA are struggling to get insights from their data quickly without having to move it out of SAP. A key technology trend for 2022, Decision Intelligence, is what's next in analytics for SAP BW and HANA. It enables organizations to more quickly gain insights needed to make decisions, act faster, capitalize on opportunities and drive innovation. Imagine having the ability to scale for any data, any person, and any analytics need from the simple to the sophisticated. In this session, we'll talk about the barriers to getting insights from SAP, new technology developments in data and analytics, and share examples of companies who have elevated their analytics game on SAP.

  • Day 2: Wednesday, July 20. 11 a.m. – 11:50 a.m.

The “Beyond ERP” Challenge: Maximizing the Use of SAP with Your Company’s Data Lake
Presenters: Cristina Martin Greysman, WW Head of SAP on AWS Partner & Alliance Strategy and Dave Henry, Senior Vice President of Strategic Alliances, Pyramid
Abstract: The adoption of data lakes is well underway. This includes how customers get more from their SAP investments using data lakes. However, deploying data lakes while integrating SAP systems can be daunting as customers get used to how it all comes together. Yet the use cases which combine data from SAP and data lakes are compelling. Through the lens of a customer case study, this session examines the business drivers for using data lakes with SAP. We introduce an agile approach to accessing, analyzing, and blending diverse data sets that insulates end-users from the underlying data architecture while ensuring security and strengthening IT governance.

There’s More! Attend Two Pyramid Impact20 Sessions

  • Take Your SAP Investment to the Next Level with Pyramid Analytics with Kevin Kratzer, Solutions Engineer, Pyramid Analytics. Tuesday, July 19. 3:30 p.m. – 3:50 p.m.
  • I Have Data Outside SAP—How Can I Get a Complete View of My Business Without Moving All My Data Around? with Matt Chapin, Solutions Engineer, Pyramid Analytics. Tuesday, July 19. 4:00 p.m. – 4:20 p.m.

Decision Intelligence is the Next Big Data Analytics Innovation

The next major innovation in analytics is Artificial Intelligence (AI). Applying AI across Data Prep, Business Analytics, and Data Science is what separates Decision Intelligence from traditional business intelligence tools such as Microsoft Power BI, Qlik, and Tableau. AI lowers the skills barrier by automating the highly technical work needed to prepare and analyze data and create and share reports and dashboards.

The Pyramid Decision Intelligence Platform delivers data-driven insights for anyone to make faster, more intelligent decisions. The Pyramid Platform provides instant access to any data, enables automated governed self-service for any person, and serves any analytics need, from the simple to the sophisticated. By uniquely combining Data Prep, Business Analytics, and Data Science with AI guidance in a single environment, the Pyramid Platform reduces cost and complexity while accelerating growth and innovation. This enables a strategic, organization-wide approach to Business Intelligence and Analytics.

About Pyramid Analytics

Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for anyone to make faster, more intelligent decisions. The Pyramid Decision Intelligence Platform provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Schedule a demo.

Pyramid Analytics is incorporated in Amsterdam and has regional headquarters in global innovation and business centers, including London, New York City, and Tel-Aviv. Our team lives worldwide because geography should not be a barrier to talent and opportunity. Investors include H.I.G. Growth Partners, Jerusalem Venture Partners (JVP), Sequoia Capital, and Viola Growth. Learn more at Pyramid Analytics.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

UK
Susie Evershed
Resonance
+44 7966 145092
pyramidanalytics@resonancecrowd.com

US
Heather Racicot
Resonance
+1 360-632-5616
pyramidanalytics@resonancecrowd.com

Chas Kielt
Vice President of Global Corporate Communications, Pyramid Analytics
617.687.3371
chas.kielt@pyramidanalytics.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 15:23:00 EEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release

Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned

Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre

Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release

Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me

BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release

Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye